AmerisourceBergen Corp. (ABC) Shares Bought by USS Investment Management Ltd
USS Investment Management Ltd increased its position in AmerisourceBergen Corp. (NYSE:ABC) by 32.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 299,600 shares of the company’s stock after acquiring an additional 73,800 shares during the period. USS Investment Management Ltd’s holdings in AmerisourceBergen were worth $27,511,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Atria Investments LLC grew its holdings in AmerisourceBergen by 18.3% during the fourth quarter. Atria Investments LLC now owns 8,990 shares of the company’s stock valued at $825,000 after purchasing an additional 1,391 shares during the period. Ridgewood Investments LLC grew its holdings in AmerisourceBergen by 16.7% during the fourth quarter. Ridgewood Investments LLC now owns 4,093 shares of the company’s stock valued at $376,000 after purchasing an additional 586 shares during the period. Bremer Trust National Association grew its holdings in AmerisourceBergen by 4.5% during the fourth quarter. Bremer Trust National Association now owns 13,758 shares of the company’s stock valued at $1,264,000 after purchasing an additional 595 shares during the period. Hexavest Inc. grew its holdings in AmerisourceBergen by 1.5% during the fourth quarter. Hexavest Inc. now owns 649,136 shares of the company’s stock valued at $59,604,000 after purchasing an additional 9,637 shares during the period. Finally, Addenda Capital Inc. bought a new stake in AmerisourceBergen during the fourth quarter valued at about $4,599,000. 67.83% of the stock is owned by institutional investors.
In other news, CFO Tim G. Guttman sold 11,600 shares of the business’s stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $74.28, for a total value of $861,648.00. Following the transaction, the chief financial officer now directly owns 40,326 shares in the company, valued at $2,995,415.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman Steven H. Collis sold 21,350 shares of the business’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $76.94, for a total value of $1,642,669.00. Following the completion of the transaction, the chairman now owns 260,226 shares in the company, valued at $20,021,788.44. The disclosure for this sale can be found here. Insiders sold 203,823 shares of company stock worth $17,145,148 over the last 90 days. Company insiders own 27.40% of the company’s stock.
Shares of AmerisourceBergen Corp. (ABC) traded up $0.86 during trading on Tuesday, hitting $99.00. The stock had a trading volume of 1,469,300 shares, compared to its average volume of 1,348,022. AmerisourceBergen Corp. has a fifty-two week low of $71.90 and a fifty-two week high of $99.00. The stock has a market capitalization of $21,880.00, a P/E ratio of 61.11, a price-to-earnings-growth ratio of 1.68 and a beta of 0.99. The company has a quick ratio of 0.48, a current ratio of 0.91 and a debt-to-equity ratio of 1.83.
AmerisourceBergen (NYSE:ABC) last announced its quarterly earnings data on Thursday, November 2nd. The company reported $1.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.32 by $0.01. AmerisourceBergen had a return on equity of 56.29% and a net margin of 0.27%. The business had revenue of $39.12 billion for the quarter, compared to the consensus estimate of $40.10 billion. During the same period in the previous year, the business earned $1.30 earnings per share. The business’s revenue was up 4.2% on a year-over-year basis. analysts forecast that AmerisourceBergen Corp. will post 6.19 earnings per share for the current year.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen Corp. (NYSE:ABC).
Receive News & Stock Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related stocks with our FREE daily email newsletter.